Latest news
BioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSciAllSci · Fri, 07 Aug 2026 16:28:01 GMTSino Bio's benmelstobart-anlotinib regimen adds new China indication in first-line squamous NSCLC - AllSciAllSci · Fri, 07 Aug 2026 16:21:02 GMTEU clears label expansion for Bavarian Nordic's Mpox vaccine to children as young as two - AllSciAllSci · Fri, 07 Aug 2026 13:40:45 GMT